1-3 of 3
Gwendolyn Binder
Close
Sort by
Journal Articles

Phase I/IIa Study of Genetically Engineered NY-ESO-1 SPEAR T-Cells Administered Following Autologous Stem Cell Transplant in HLA-a*02 + Patients with Advanced Multiple Myeloma: Long Term Follow-up (NCT01352286)

Aaron P. Rapoport, MD, Edward A Stadtmauer, MD, Karen Chagin, MD, Thomas Faitg, Malini Iyengar, Trupti Trivedi, Elliot Norry, MD, Tom Holdich, MD, Gwendolyn Binder-Scholl, PhD, Rafael Amado, MD, Frank Fang
Journal: Blood
Blood (2017) 130 (Supplement 1): 845.
https://doi.org/10.1182/blood.V130.Suppl_1.845.845
Published: 2017
Journal Articles

Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV

Clinical Trials & Observations
Pablo Tebas, David Stein, Gwendolyn Binder-Scholl, Rithun Mukherjee, Troy Brady, Tessio Rebello, Laurent Humeau, Michael Kalos, Emmanouil Papasavvas, Luis J. Montaner, Daniel Schullery, Farida Shaheen, Andrea L. Brennan, Zhaohui Zheng, Julio Cotte, Vladimir Slepushkin, Elizabeth Veloso, Adonna Mackley, Wei-Ting Hwang, Faten Aberra, Jenny Zhan, Jean Boyer, Ronald G. Collman, Frederic D. Bushman, Bruce L. Levine, Carl H. June
Journal: Blood
Blood (2013) 121 (9): 1524–1533.
https://doi.org/10.1182/blood-2012-07-447250
Published: 2013
Includes: Supplemental data
Journal Articles

ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells

Brian M. Davis, Laurent Humeau, Vladimir Slepushkin, Gwendolyn Binder, Lauren Korshalla, Yajin Ni, E. Oluwakemi Ogunjimi, Lan-Fei Chang, Xiaobin Lu, Boro Dropulic
Journal: Blood
Blood (2004) 104 (2): 364–373.
https://doi.org/10.1182/blood-2003-07-2363
Published: 2004